228 related articles for article (PubMed ID: 7862142)
1. Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product.
Nakagama H; Heinrich G; Pelletier J; Housman DE
Mol Cell Biol; 1995 Mar; 15(3):1489-98. PubMed ID: 7862142
[TBL] [Abstract][Full Text] [Related]
2. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
[TBL] [Abstract][Full Text] [Related]
3. Overlapping RNA and DNA binding domains of the wt1 tumor suppressor gene product.
Bardeesy N; Pelletier J
Nucleic Acids Res; 1998 Apr; 26(7):1784-92. PubMed ID: 9512553
[TBL] [Abstract][Full Text] [Related]
4. High affinity binding sites for the Wilms' tumour suppressor protein WT1.
Hamilton TB; Barilla KC; Romaniuk PJ
Nucleic Acids Res; 1995 Jan; 23(2):277-84. PubMed ID: 7862533
[TBL] [Abstract][Full Text] [Related]
5. LLC-PK1 cell growth is repressed by WT1 inhibition of G-protein alpha i-2 protooncogene transcription.
Kinane TB; Finder JD; Kawashima A; Brown D; Abbate M; Fredericks WJ; Sukhatme VP; Rauscher FJ; Ercolani L
J Biol Chem; 1995 Dec; 270(51):30760-4. PubMed ID: 8530517
[TBL] [Abstract][Full Text] [Related]
6. Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells.
Menke AL; Riteco N; van Ham RC; de Bruyne C; Rauscher FJ; van der Eb AJ; Jochemsen AG
Oncogene; 1996 Feb; 12(3):537-46. PubMed ID: 8637710
[TBL] [Abstract][Full Text] [Related]
7. RNA binding by the Wilms tumor suppressor zinc finger proteins.
Caricasole A; Duarte A; Larsson SH; Hastie ND; Little M; Holmes G; Todorov I; Ward A
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7562-6. PubMed ID: 8755514
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the DNA binding characteristics of the related zinc finger proteins WT1 and EGR1.
Hamilton TB; Borel F; Romaniuk PJ
Biochemistry; 1998 Feb; 37(7):2051-8. PubMed ID: 9485332
[TBL] [Abstract][Full Text] [Related]
9. Characterization of RNA aptamer binding by the Wilms' tumor suppressor protein WT1.
Zhai G; Iskandar M; Barilla K; Romaniuk PJ
Biochemistry; 2001 Feb; 40(7):2032-40. PubMed ID: 11329270
[TBL] [Abstract][Full Text] [Related]
10. Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence.
Rauscher FJ; Morris JF; Tournay OE; Cook DM; Curran T
Science; 1990 Nov; 250(4985):1259-62. PubMed ID: 2244209
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus.
Morris JF; Madden SL; Tournay OE; Cook DM; Sukhatme VP; Rauscher FJ
Oncogene; 1991 Dec; 6(12):2339-48. PubMed ID: 1662794
[TBL] [Abstract][Full Text] [Related]
12. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter.
McCoy C; McGee SB; Cornwell MM
Cell Growth Differ; 1999 Jun; 10(6):377-86. PubMed ID: 10392899
[TBL] [Abstract][Full Text] [Related]
13. In situ expression of the early growth response gene-1 during murine nephrogenesis.
Rackley RR; Kessler PM; Campbell C; Williams BR
J Urol; 1995 Aug; 154(2 Pt 2):700-5. PubMed ID: 7609158
[TBL] [Abstract][Full Text] [Related]
14. Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product.
Dey BR; Sukhatme VP; Roberts AB; Sporn MB; Rauscher FJ; Kim SJ
Mol Endocrinol; 1994 May; 8(5):595-602. PubMed ID: 8058069
[TBL] [Abstract][Full Text] [Related]
15. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG
Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497
[TBL] [Abstract][Full Text] [Related]
16. A novel target for the Wilms' tumour suppressor protein (WT1) is bound by a unique combination of zinc fingers.
Little MH; Holmes G; Pell L; Caricasole A; Duarte A; Law M; Ward A; Wainwright B
Oncogene; 1996 Oct; 13(7):1461-9. PubMed ID: 8875984
[TBL] [Abstract][Full Text] [Related]
17. Identification of the cellular protein encoded by the human Wilms' tumor (WT1) gene.
Telerman A; Dodemont H; Degraef C; Galand P; Bauwens S; Van Oostveldt P; Amson RB
Oncogene; 1992 Dec; 7(12):2545-8. PubMed ID: 1334252
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional repression mediated by the WT1 Wilms tumor gene product.
Madden SL; Cook DM; Morris JF; Gashler A; Sukhatme VP; Rauscher FJ
Science; 1991 Sep; 253(5027):1550-3. PubMed ID: 1654597
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional repression of human insulin-like growth factor-II P4 promoter by Wilms' tumor suppressor WT1.
Lee YI; Kim SJ
DNA Cell Biol; 1996 Feb; 15(2):99-104. PubMed ID: 8634146
[TBL] [Abstract][Full Text] [Related]
20. DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1.
Drummond IA; Rupprecht HD; Rohwer-Nutter P; Lopez-Guisa JM; Madden SL; Rauscher FJ; Sukhatme VP
Mol Cell Biol; 1994 Jun; 14(6):3800-9. PubMed ID: 8196623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
